Liver transplantation for hepatocarcinoma

Area of Science:

• Hepatobiliary Surgery
• Transplant Oncology
• Gastroenterology

Background:

• Hepatobiliary malignancies represent a significant indication for liver transplantation.
• Understanding outcomes for hepatocellular carcinoma (HCC) and cholangiocarcinoma is crucial for patient selection.

Purpose of the Study:

• To evaluate the outcomes of orthotopic liver transplantation in patients with primary or secondary hepatobiliary malignancies.
• To assess recurrence rates and survival in patients with HCC and cholangiocarcinoma post-transplantation.

Main Methods:

• Retrospective analysis of 592 liver transplantations performed between January 1980 and May 1991.
• Focus on 89 patients with hepatobiliary malignancies, including 66 with HCC and 13 with cholangiocarcinoma.

Main Results:

• Overall 5-year survival for HCC was 18.6%, with a 37.5% recurrence rate. Cirrhotic livers showed a 37.7% 5-year survival recurrence.
• For cholangiocarcinoma, the 5-year survival rate was 23.8%, with a 46.2% recurrence rate.
• Postoperative hemorrhage was the most common early cause of death; long-term survivors demonstrate the possibility of cure.

Conclusions:

• Despite high recurrence rates, liver transplantation is an appropriate indication for selected patients with HCC.
• Liver transplantation offers a potential, albeit rare, long-term cure for primary liver malignancies.
• Expanding indications for liver transplantation necessitate continued evaluation of outcomes in malignancy cases.